(1)
Evaluation of Soluble PD-1 and PD-L1 in Iraqi Type 2 Diabetes Mellitus (T2DM) Patients With Chronic Toxoplasmosis. MLU 2020, 20 (3), 609-615. https://doi.org/10.37506/mlu.v20i3.1467.